Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -2.37% is 91% above its 5-year average of -25.75%, around the middle of its 5-year range (-68.09%–31.39%).
As of the fiscal period ended Wednesday, December 31, 2025. 88.93% above its 12-month average of -21.41%.
Annual fiscal-year return on equity; no daily interpolation.
RETURN ON EQUITY (ROE)
-2.37%
RETURN ON EQUITY (ROE) AVG TTM
-21.41%
RETURN ON EQUITY (ROE) AVG 3Y
-36.14%
RETURN ON EQUITY (ROE) AVG 5Y
-25.75%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+88.93%
CURRENT VS 3Y AVG
+93.44%
CURRENT VS 5Y AVG
+90.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
10.61%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-122.34%
vs the sector median at left
Oscar Health, Inc.
Market Cap
$7.81B
Return on Equity (ROE)
-2.37%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$8.18B
Return on Equity (ROE)
-57.18%
TTM Avg
-651.33%
3Y Avg
-315.37%
5Y Avg
-198.08%
Market Cap
$7.06B
Return on Equity (ROE)
-2.97%
TTM Avg
25.09%
3Y Avg
5.57%
5Y Avg
0.40%
Market Cap
$9.23B
Return on Equity (ROE)
23.25%
TTM Avg
25.41%
3Y Avg
19.99%
5Y Avg
14.02%
Market Cap
$9.36B
Return on Equity (ROE)
3.10%
TTM Avg
-8.94%
3Y Avg
-15.72%
5Y Avg
1.14%
Market Cap
$10.19B
Return on Equity (ROE)
-0.17%
TTM Avg
18.91%
3Y Avg
22.60%
5Y Avg
24.60%
Market Cap
$10.21B
Return on Equity (ROE)
12.09%
TTM Avg
11.88%
3Y Avg
12.69%
5Y Avg
13.50%
Market Cap
$10.37B
Return on Equity (ROE)
-87.68%
TTM Avg
-49.03%
3Y Avg
-18.16%
5Y Avg
-9.00%
Market Cap
$10.39B
Return on Equity (ROE)
20.31%
TTM Avg
18.80%
3Y Avg
15.17%
5Y Avg
15.31%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oscar Health, Inc. (OSCR) | $7.81B | -2.37% | -21.41% | -36.14% | -25.75% |
| Tempus AI, Inc. (TEM)vs › | $8.18B | -57.18% | -651.33% | -315.37% | -198.08% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.06B | -2.97% | 25.09% | 5.57% | 0.40% |
| Insulet Corp. (PODD)vs › | $9.23B | 23.25% | 25.41% | 19.99% | 14.02% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.36B | 3.10% | -8.94% | -15.72% | 1.14% |
| Molina Healthcare, Inc. (MOH)vs › | $10.19B | -0.17% | 18.91% | 22.60% | 24.60% |
| Henry Schein, Inc. (HSIC)vs › | $10.21B | 12.09% | 11.88% | 12.69% | 13.50% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -87.68% | -49.03% | -18.16% | -9.00% |
| Universal Health Services, Inc. (UHS)vs › | $10.39B | 20.31% | 18.80% | 15.17% | 15.31% |
| Bio-Techne Corporation (TECH)vs › | $11.27B | 5.25% | 5.98% | 10.62% | 11.34% |
ROE
-2.4%
ROA
-0.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2025-12-31 | -45.33% |
| 2024-12-31 | 2.51% |
| 2023-12-31 | -33.67% |
| 2022-12-31 | -68.09% |
| 2021-12-31 | -41.28% |
| 2020-12-31 | 31.39% |
| 2019-12-31 | 27.63% |
